Department of Corrections officials in June replaced the anesthetic sodium thiopental, the first of three drugs used in lethal injections, with pentobarbital sodium. The manufacturer of sodium thiopental stopped making the drug early this year, part of a nationwide drug shortage that is affecting hospitals as well as correctional facilities.
Lundbeck, the Danish manufacturer that produces pentobarbital, announced the drug is untested and unsafe for use in lethal injections. The company has since stopped selling the drug to those who intend to resell it for lethal injections. The drug is not FDA-approved as an anesthetic, thought it has been used in at least 15 executions in other states.
Read the Palm Beach Post report on lethal injections.
Related Articles on Anesthesia:
Ohio’s Lourdes University to Offer Only Nurse Anesthesia Program in Northwest Ohio
American Anesthesiology Acquires Palm Beach Physician Practice
Diabetes Drug Can Control Inflammation That Causes Pain, Nerve Damage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.